Longwood Fund Management Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
12
- Investments
-
85
- Portfolio
-
27
- Exits
-
32
Longwood Fund Management General Information
Company Description
Founded in 2010, Longwood Fund is a venture capital firm based in Boston, Massachusetts. The firm prefers to invest in the healthcare, pharmaceutical, and biotechnology sectors. This firm is a Registered Investment Adviser (RIA).
Business Details
Website
www.longwoodfund.comYear Founded
Investor Status
Primary Investor Type
Other Investor Types
Corporate Office
- The Prudential Tower, 800 Boylston Street
- Suite 1715
- Boston, MA 02199
- United States
Longwood Fund Management Investments (85)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Khartis Therapeutics | 13-Aug-2026 | Early Stage VC | Drug Discovery | Startup | ||
| Crystalys Therapeutics | 22-Jul-2026 | Drug Discovery | Clinical Trials - Phase 3 | |||
| Avenzo Therapeutics | 01-Jun-2026 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Coultreon Biopharma | 28-Apr-2026 | Drug Discovery | Generating Revenue | |||
| Sidewinder Therapeutics | 25-Mar-2026 | Drug Discovery | Generating Revenue | |||
| Neomorph | 17-Mar-2026 | Drug Discovery | Clinical Trials - General | |||
| Mediar Therapeutics | 10-Dec-2025 | Drug Discovery | Clinical Trials - Phase 1 | |||
| AAVantgarde Bio | 03-Nov-2025 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Crystalys Therapeutics | 30-Sep-2025 | Early Stage VC | Drug Discovery | Clinical Trials - Phase 3 | ||
| Avenzo Therapeutics | 22-Aug-2025 | Early Stage VC | Drug Discovery | Clinical Trials - Phase 1 |
Longwood Fund Management Exits (32)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Be Biopharma | 05-Oct-2026 | Out of Business | |
| Pyxis Oncology | 01-Oct-2026 | ||
| Immunitas Therapeutics | 12-May-2026 | ||
| Colorescience | 02-Feb-2026 | ||
| Doppler Bio | 07-Jan-2026 | ||
| Evommune | 06-Nov-2025 | ||
| Tome Biosciences | 03-Nov-2025 | ||
| Interius BioTherapeutics | 14-Oct-2025 | ||
| BridgeBio Oncology Therapeutics | 11-Aug-2025 | Reverse Merger | |
| ImmuneID | 22-Nov-2024 | Out of Business |
Longwood Fund Management Investments by Industry, Year, and Region
Longwood Fund Management Co-Investors (163)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Alexandria Venture Investments | 7 |
|
|
||
| Astellas Venture Management |
|
|
|||
| ARCH Venture Partners |
|
|
|||
| Alta Partners |
|
|
|||
| Forbion |
|
|
Longwood Fund Management FAQs
-
What is Longwood Fund Management?
Founded in 2010, Longwood Fund is a venture capital firm based in Boston, Massachusetts.
-
When was Longwood Fund Management founded?
Longwood Fund Management was founded in 2010.
-
Where is Longwood Fund Management headquartered?
Longwood Fund Management is headquartered in Boston, MA.
-
What is Longwood Fund Management's total asset value?
Longwood Fund Management has around in total assets under management.
-
How many investments has Longwood Fund Management made?
Longwood Fund Management has made 85 investments.
-
What has Longwood Fund Management invested in?
Longwood Fund Management has made numerous investments in companies like Khartis Therapeutics, Crystalys Therapeutics, and Avenzo Therapeutics within the Drug Discovery industry.
-
What has Longwood Fund Management invested in recently?
Longwood Fund Management's latest investment was on 13-Aug-2026 in Khartis Therapeutics, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process